Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure

BACKGROUND: Sacubitril/valsartan (S/V) improves outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term hemodynamic effects of S/V are limited. METHODS: In this prospective observational study, 37 outpatients with chroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Hanna, Frey, Norbert, Estler, Bent, Mäck, Mirjam, Schlegel, Philipp, Beckendorf, Jan, Frankenstein, Lutz, Täger, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493168/
https://www.ncbi.nlm.nih.gov/pubmed/36136241
http://dx.doi.org/10.1007/s40256-022-00549-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493168/
https://www.ncbi.nlm.nih.gov/pubmed/36136241
http://dx.doi.org/10.1007/s40256-022-00549-2

Ejemplares similares